• Aradigm Awarded Grant to Investigate Treatment of Pulmonary Mycobacterial Infections with Ciprofloxacin Therapies
  • Nitric Oxide Delivered to First Patient Enrolled in Phase 2 Trial for Serious Respiratory Infection
  • Bronchiectasis is Leading Risk Factor for Chronic Cough, Danish Researchers Find
  • Researchers Identify Antibodies That Could Predict Whether Bronchiectasis Patients Develop Rheumatoid Arthritis
  • New Drug Application Submitted for Linhaliq as Treatment of Pseudomonas Aeruginosa Infection in NCFBE Patients
  • Electromed Launches SmartVest Connect Wireless Technology for Patients with Compromised Pulmonary Function
  • Bayer’s Ciprofloxacin DPI Shows Promise in Treating Non-cystic Fibrosis Bronchiectasis
  • SmartVest for Mucus Clearance Reduces Bronchiectasis-related Exacerbations, According to Study
  • Bronchiectasis Common in Patients With Severe Uncontrolled Asthma, Greek Study Finds
  • Antibody Test Identifies Chronic Pseudomonas Lung Infection in Bronchiectasis Patients
  • Lipitor May Help Bronchiectasis Patients Infected with P. aeruginosa, Study Finds
  • Mortality Higher in Bronchiectasis Patients Who Also Have COPD